← Open Payments lookup

JUSTIN MATAR: Open Payments

NPI 1265193080 · CORONA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,844 in 145 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $1,059 · 2025 $2,844

Food & beverage: $2,772Education: $73
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.33$656
Neurocrine BioSciences, Inc.25$533
E.R. Squibb & Sons, L.L.C.25$448
Teva Pharmaceuticals USA, Inc.18$426
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)19$337
Alkermes, Inc.11$158
ABBVIE INC.4$79
Janssen Pharmaceuticals, Inc1$41
Almatica Pharma LLC2$39
Axsome Therapeutics, Inc.2$39

Products named: INGREZZA, REXULTI, COBENFY, CAPLYTA, AUSTEDO XR, UZEDY, ARISTADA, ABILIFY ASIMTUFII.

Industry payments across CA — which companies pay providers there.